Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J RENARD

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Phase II trial with Brequinar (DUP-785, NSC 368390) in patients with metastatic colorectal cancer: a study of the Early Clinical Trials Group of the EORTCP F Dodion, T Wagener, G Stoter, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of flutamide in advanced ovarian cancer: an EORTC Gynaecological Cancer Cooperative Group studyS Tumolo, B R Rao, M E van der Burg, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of weekly 4'-epidoxorubicin in patients with metastatic squamous cell cancer of the cervix: an EORTC Gynaecological Cancer Cooperative Group StudyM E van der Burg, S Monfardini, J P Guastalla, et al.
Human Molecular Genetics|March 21, 1998
Comparative analysis of the phosphomannomutase genes PMM1, PMM2 and PMM2psi: the sequence variation in the processed pseudogene is a reflection of the mutations found in the functional geneE Schollen, E Pardon, L Heykants, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1992
High-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer: a phase II study. EORTC Genito-Urinary Tract Cancer Co-operative Group. EORTC Early Clinical Trials GroupG Stoter, A Akdas, S D Fosså, et al.
The New England Journal of Medicine|October 8, 1981
Quality of institutional participation in multicenter clinical trialsR J Sylvester, H M Pinedo, M De Pauw, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1984
Phase II study of amsacrine in refractory lymphomas. A report of the EORTC Early Clinical Trials GroupV H Bramwell, E E Holdener, P Siegenthaler, et al.
Clinical Chemistry|January 1, 1985
Enzyme-antigen immunoassay for human placental alkaline phosphatase in serum and tissue extracts, and its application as a tumor markerD E Pollet, E J Nouwen, J B Schelstraete, et al.
Investigational New Drugs|January 1, 1985
Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC)E E Holdener, H H Hansen, H Høst, et al.
Archives of Orthopaedic and Trauma Surgery|March 30, 2000
The saddle prosthesis in pelvic primary and secondary musculoskeletal tumors: functional results at several postoperative intervalsA J Renard, R P Veth, H W Schreuder, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Phase II trial with Brequinar (DUP-785, NSC 368390) in patients with metastatic colorectal cancer: a study of the Early Clinical Trials Group of the EORTCP F Dodion, T Wagener, G Stoter, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of flutamide in advanced ovarian cancer: an EORTC Gynaecological Cancer Cooperative Group studyS Tumolo, B R Rao, M E van der Burg, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of weekly 4'-epidoxorubicin in patients with metastatic squamous cell cancer of the cervix: an EORTC Gynaecological Cancer Cooperative Group StudyM E van der Burg, S Monfardini, J P Guastalla, et al.
Human Molecular Genetics|March 21, 1998
Comparative analysis of the phosphomannomutase genes PMM1, PMM2 and PMM2psi: the sequence variation in the processed pseudogene is a reflection of the mutations found in the functional geneE Schollen, E Pardon, L Heykants, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1992
High-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer: a phase II study. EORTC Genito-Urinary Tract Cancer Co-operative Group. EORTC Early Clinical Trials GroupG Stoter, A Akdas, S D Fosså, et al.
The New England Journal of Medicine|October 8, 1981
Quality of institutional participation in multicenter clinical trialsR J Sylvester, H M Pinedo, M De Pauw, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1984
Phase II study of amsacrine in refractory lymphomas. A report of the EORTC Early Clinical Trials GroupV H Bramwell, E E Holdener, P Siegenthaler, et al.
Clinical Chemistry|January 1, 1985
Enzyme-antigen immunoassay for human placental alkaline phosphatase in serum and tissue extracts, and its application as a tumor markerD E Pollet, E J Nouwen, J B Schelstraete, et al.
Investigational New Drugs|January 1, 1985
Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC)E E Holdener, H H Hansen, H Høst, et al.
Archives of Orthopaedic and Trauma Surgery|March 30, 2000
The saddle prosthesis in pelvic primary and secondary musculoskeletal tumors: functional results at several postoperative intervalsA J Renard, R P Veth, H W Schreuder, et al.
Pageof 10